News
Market Data
Register to chat with like-minded investors on our interactive forums.
The current IMGN market cap is 7.79B. The company's latest EPS is USD -0.8372 and P/E is -35.05.
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 14.16M | 15.38M | 41.17M | 49.87M | 83.15M |
| Operating Income | -61.05M | -77.43M | -59.56M | -42.39M | -4.19M |
| Net Income | -62.02M | -77.76M | -59.01M | -41.01M | -4.25M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 53.45M | 82.27M | 132.3M | 69.86M | 108.78M |
| Operating Income | -161.45M | -89.67M | -22.38M | -125.07M | -220.89M |
| Net Income | -168.84M | -104.13M | -44.37M | -139.3M | -222.93M |
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 422.3M | 358.8M | 348.94M | 288.35M | 714.33M |
| Total Liabilities | 172.46M | 180.79M | 193.11M | 166.43M | 223.49M |
| Total Equity | 249.83M | 178.01M | 155.83M | 121.92M | 490.84M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 295.38M | 235.26M | 355.07M | 525.77M | 348.94M |
| Total Liabilities | 284.41M | 311.38M | 265.5M | 200.18M | 193.11M |
| Total Equity | 10.97M | -76.12M | 89.57M | 325.59M | 155.83M |
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -105.39M | -169.6M | -229.8M | -73.72M | -140.46M |
| Investing | -514k | -1.12M | -1.36M | -209k | -287k |
| Financing | 1.03M | 1.48M | 27.55M | 39k | 437.6M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -166.42M | -88.37M | -78.62M | -169.42M | -229.8M |
| Investing | -5.25M | -533k | 509k | -1.43M | -1.36M |
| Financing | 166.81M | 2.87M | 195.74M | 355.74M | 27.55M |
| Market Cap | 7.79B |
| Price to Earnings Ratio | -35.05 |
| Price to Sales Ratio | 71.82 |
| Price to Cash Ratio | 28.39 |
| Price to Book Ratio | 50.13 |
| Dividend Yield | - |
| Shares Outstanding | 266.26M |
| Average Volume (1 week) | 3.63M |
| Average Volume (1 Month) | 5.66M |
| 52 Week Change | 475.81% |
| 52 Week High | 29.44 |
| 52 Week Low | 3.605 |
| Spread (Intraday) | 0.05 (0.17%) |
| Company Name | ImmunoGen Inc |
| Address |
830 winter street waltham, massachusetts 02451 |
| Website | https://www.immunogen.com/ |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
